255 related articles for article (PubMed ID: 10834306)
1. Effects of natriuretic peptides (ANP, BNP, CNP) on catecholamine synthesis and TH mRNA levels in PC12 cells.
Takekoshi K; Ishii K; Isobe K; Nomura F; Nammoku T; Nakai T
Life Sci; 2000 Apr; 66(22):PL303-11. PubMed ID: 10834306
[TBL] [Abstract][Full Text] [Related]
2. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH
Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124
[TBL] [Abstract][Full Text] [Related]
3. C-type natriuretic peptide stimulates catecholamine synthesis through the accumulation of cyclic GMP in cultured bovine adrenal medullary cells.
Tsutsui M; Yanagihara N; Minami K; Kobayashi H; Nakashima Y; Kuroiwa A; Izumi F
J Pharmacol Exp Ther; 1994 Feb; 268(2):584-9. PubMed ID: 7906732
[TBL] [Abstract][Full Text] [Related]
4. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
Rodriguez-Pascual F; Miras-Portugal MT; Torres M
Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
[TBL] [Abstract][Full Text] [Related]
6. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism.
Suenobu N; Shichiri M; Iwashina M; Marumo F; Hirata Y
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):140-6. PubMed ID: 9888876
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
Yamamoto K; Ikeda U; Shimada K
J Mol Cell Cardiol; 1997 Sep; 29(9):2375-82. PubMed ID: 9299361
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
Crook RB; Chang AT
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
[TBL] [Abstract][Full Text] [Related]
10. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
11. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of homologous natriuretic peptides on growth hormone and prolactin release in the tilapia, Oreochromis mossambicus.
Fox BK; Naka T; Inoue K; Takei Y; Hirano T; Grau EG
Gen Comp Endocrinol; 2007 Jan; 150(2):270-7. PubMed ID: 17107675
[TBL] [Abstract][Full Text] [Related]
13. Modulation by brain natriuretic peptide of GABA receptors on rat retinal ON-type bipolar cells.
Yu YC; Cao LH; Yang XL
J Neurosci; 2006 Jan; 26(2):696-707. PubMed ID: 16407567
[TBL] [Abstract][Full Text] [Related]
14. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling.
Lee SJ; Kim SZ; Cui X; Kim SH; Lee KS; Chung YJ; Cho KW
Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H208-21. PubMed ID: 10644601
[TBL] [Abstract][Full Text] [Related]
15. Natriuretic peptide-induced relaxation of myometrium from the pregnant guinea pig is not mediated by guanylate cyclase activation.
Carvajal JA; Aguan K; Thompson LP; Buhimschi IA; Weiner CP
J Pharmacol Exp Ther; 2001 Apr; 297(1):181-8. PubMed ID: 11259543
[TBL] [Abstract][Full Text] [Related]
16. C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line.
Suda M; Tanaka K; Yasoda A; Komatsu Y; Chusho H; Miura M; Tamura N; Ogawa Y; Nakao K
J Bone Miner Metab; 2002; 20(3):136-41. PubMed ID: 11984695
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
Herring N; Zaman JA; Paterson DJ
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2318-27. PubMed ID: 11709398
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and renal effect of CNAAC: An innovatively designed natriuretic peptide.
Zhang S; Geng X; Zhao L; Li J; Tian F; Wang Y; Fan R; Feng N; Liu J; Cheng L; Pei J
Eur J Pharmacol; 2015 Aug; 761():180-8. PubMed ID: 25979857
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
Hamad AM; Range S; Holland E; Knox AJ
Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
[TBL] [Abstract][Full Text] [Related]
20. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
